LAM Biomarker Innovation Summit Grant

The LAM Biomarker Innovation Summit, a highly interactive two-day meeting produced recommendations for short and long term LAM biomarker development strategies. Over 45 LAM scientists and biomarker thought leaders joined together and presented current progress, discussed future priorities and provided recommendations.

The LAM community knows that identification of biomarkers will help improve therapies and also help women living with LAM to make more informed decisions throughout their lives. As a result of this summit, the following grants were issued and are currently being investigated.

LAM Biomarker Innovation Summit Grant Awards
Grant Award Winners
Brian Bartholmai, MD
Mayo Clinic
Rochester

CALIPER HRCT Analysis in LAM


Grant Award Winners
Simon Johnson, MD
The University of Nottingham
United Kingdom

Discovery of Serum Markers of Disease Activity for LAM


Grant Award Winners
David Kwiatkowski, MD, PhD
Brigham and Women's Hospital
Boston

TSC2 Mutation Analysis as a Biomarker for Lymphangioleiomyomatosis (LAM)


Grant Award Winners
Carmen Priolo, MD, PhD
Brigham and Women's Hospital
Boston

Imaging Biomarkers to Trace Metabolic Activity of LAM



Grant Award Winners
Raymond Yeung, MD
Washington University
Seattle

Cell-free DNA Quantitation and Mutation Analyses in LAM